Exhibiting at VIV Asia 2025

About Dong Bang Co., Ltd.

Dong Bang Co., Ltd., headquartered in Pyeongchang County, South Korea, is a leading manufacturer specializing in animal healthcare products. Established with a strong focus on veterinary medicine, the company has built a reputation for high-quality pharmaceuticals catering to the livestock and pet industries. With decades of expertise, Dong Bang has positioned itself as a key player in South Korea’s animal health sector, serving both domestic and international markets.

Core Business and Specialization

Dong Bang Co., Ltd. focuses on developing and manufacturing a wide range of veterinary products, including:

• Antibiotics – Essential for treating bacterial infections in livestock and pets.
• Hormones – Used for reproductive health and growth enhancement in animals.
• Probiotics – Supporting gut health and immunity in various species.
• Vitamins and Minerals – Ensuring nutritional balance for optimal animal health.

The company emphasizes research-driven solutions to enhance animal health and productivity, leveraging advanced manufacturing techniques to ensure high efficacy and safety standards.

Manufacturing and Capabilities

Dong Bang operates state-of-the-art production facilities that comply with Good Manufacturing Practices (GMP) and other regulatory standards. The company employs cutting-edge biotechnology to develop innovative veterinary drugs and feed additives. Their production process integrates stringent quality control measures, ensuring that all products meet global safety and efficacy standards.

Key manufacturing strengths include:

• Advanced fermentation technology for probiotic development.
• Precision formulation techniques for antibiotic and hormone production.
• Sustainable production practices reducing environmental impact.

International Market Presence and Export

Dong Bang Co., Ltd. has established a strong presence in global markets, exporting veterinary pharmaceuticals to over 30 countries. The company’s international expansion is supported by strategic partnerships and a well-structured distribution network.

Export Data:

• Major export regions: Asia, Middle East, South America, and Europe.
• Key product exports: Antibiotics, probiotics, and nutritional supplements.
• Annual shipment volume: Estimated at thousands of metric tons in animal healthcare products.

The company actively participates in global trade fairs and exhibitions, fostering international collaborations and expanding its footprint in the veterinary medicine industry.

Financial Strength and Performance

Dong Bang Co., Ltd. has demonstrated consistent financial growth, with revenue increasing year over year due to rising global demand for animal healthcare solutions. The company reinvests in R&D and production capacity expansion, ensuring sustained innovation and competitiveness.

Key financial indicators:

• Revenue growth: Driven by increased exports and domestic sales.
• Investment in R&D: A significant portion of annual revenue allocated to innovation.
• Expansion strategy: Ongoing investments in manufacturing infrastructure.

Certifications and Compliance

Dong Bang adheres to strict regulatory standards to ensure product safety and efficacy. The company holds various international certifications, including:

• Good Manufacturing Practices (GMP) Certification
• ISO Quality Management Certification
• South Korean Ministry of Agriculture Approval
• Compliance with EU and US FDA Veterinary Regulations

These certifications validate Dong Bang’s commitment to high-quality production standards, making its products globally recognized and trusted.

Major Achievements

• Expansion into 30+ global markets, solidifying international reach.
• Development of innovative probiotic formulations, enhancing livestock health.
• Recognition by South Korean authorities for excellence in veterinary pharmaceuticals.
• Strategic collaborations with international distributors, boosting export volume.

Customer Testimonials

Many veterinary professionals and distributors praise Dong Bang’s products for their high efficacy, safety, and affordability. Testimonials highlight:

• “Exceptional quality and effectiveness in livestock disease management.”
• “Reliable product supply with consistent international standards.”
• “A trusted partner in animal healthcare for over two decades.”

Future Outlook

Dong Bang Co., Ltd. aims to expand further into emerging markets, leveraging biotechnology advancements and sustainable production. The company continues to invest in research and partnerships, ensuring long-term growth and market leadership in the global animal health industry.